VITURA HEALTH LIMITED - Announcements

0.00%

7.2¢

Market Cap $47.68M

Healthcare Psychedelics

Vitura Health Limited is engaged in a diversified digital health business. The Company,... Vitura Health Limited is engaged in a diversified digital health business. The Company, through its subsidiaries, operates businesses, including Burleigh Heads Cannabis, Canview, Doctors on Demand, Cortexa, CDA Clinics, and Cannadoc. Its sales and distribution segment covers the sale and distribution of medical products, including medicinal cannabis, psychedelic drugs and smoking cessation products, and potentially others. Its clinics and services segment covers the provision of medical consultations and related services. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy, and supplier online ecosystem, Canview, which sells and distributes 430+ therapeutic product and device SKUs within Australia from about 60 international and domestic brands. Doctors on Demand is a telehealth platform business that provides primary health solutions. It also operates the Candor Medical brand, which provides prescription treatments, including access to medicinal cannabis.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

VIT	Flora JV acquires Heyday Medical Clinic	PRICE SENSITIVE	19/05/25	185.48KB	Share
VIT	Q3 FY2025 business update	PRICE SENSITIVE	12/05/25	185.84KB	Share
VIT	S&P DJI Announces March 2025 Quarterly Rebalance	PRICE SENSITIVE	07/03/25	174.42KB	Share
VIT	Vitura completes acquisition of Canview platform	PRICE SENSITIVE	26/02/25	273.86KB	Share
VIT	H1 FY2025 financial results	PRICE SENSITIVE	26/02/25	316.24KB	Share
VIT	Appendix 4D	PRICE SENSITIVE	26/02/25	128.68KB	Share
VIT	Vitura completes acquisition of Candor Medical	PRICE SENSITIVE	20/02/25	271.6KB	Share
VIT	Vitura acquires Candor Medical	PRICE SENSITIVE	12/02/25	293.16KB	Share
VIT	Vitura raises $5.1 million from Charlie Shahin AO	PRICE SENSITIVE	12/02/25	273.08KB	Share
VIT	Trading Halt	PRICE SENSITIVE	11/02/25	283.83KB	Share
VIT	Update regarding TGA proceedings	PRICE SENSITIVE	14/01/25	243.61KB	Share
VIT	Vitura JV acquires assets of Releaf Group	PRICE SENSITIVE	19/11/24	282.92KB	Share
VIT	Strategy Reset delivers positive Q1 results	PRICE SENSITIVE	28/10/24	251.14KB	Share
VIT	Vitura settles dispute with Code4 Cannabis	PRICE SENSITIVE	17/10/24	247.51KB	Share
VIT	Investor presentation	PRICE SENSITIVE	04/09/24	2.59MB	Share
VIT	FY2024 Financial Results	PRICE SENSITIVE	29/08/24	292.73KB	Share
VIT	ASX Appendix 4E - 30 June 2024	PRICE SENSITIVE	29/08/24	139.22KB	Share
VIT	Geoff Cockerill appointed CEO of Vitura	PRICE SENSITIVE	27/08/24	278.76KB	Share
VIT	VIT Strategy Reset Presentation	PRICE SENSITIVE	24/05/24	1.99MB	Share
VIT	Vitura Strategy Reset	PRICE SENSITIVE	22/05/24	752.45KB	Share
VIT	Update on Services Agreement with Code4 Cannabis	PRICE SENSITIVE	26/04/24	253.67KB	Share
VIT	Services Agreement with Code4 Cannabis	PRICE SENSITIVE	23/04/24	255.28KB	Share
VIT	Trading Halt	PRICE SENSITIVE	22/04/24	325.37KB	Share
VIT	Pause in Trading	PRICE SENSITIVE	22/04/24	115.65KB	Share
VIT	CEO transition	PRICE SENSITIVE	22/04/24	257.57KB	Share
VIT	First supply of Psilocybin	PRICE SENSITIVE	18/03/24	270.26KB	Share
VIT	Investor webinar and presentation	PRICE SENSITIVE	26/02/24	4.65MB	Share
VIT	ASX Appendix 4D	PRICE SENSITIVE	26/02/24	57.21KB	Share
VIT	Agreement executed with WholeLife Pharmacy Group	PRICE SENSITIVE	22/01/24	202.66KB	Share
VIT	Vitura adds smoking cessation product vertical	PRICE SENSITIVE	09/01/24	212.62KB	Share
VIT	Canview Services Agreement not to be extended	PRICE SENSITIVE	27/12/23	172.61KB	Share
VIT	Sale of 2 millionth unit through CanView	PRICE SENSITIVE	11/12/23	211.47KB	Share
VIT	Materials for 2023 Annual General Meeting	PRICE SENSITIVE	28/11/23	7.93MB	Share
VIT	Cortexa update - product landed	PRICE SENSITIVE	08/11/23	213.29KB	Share
VIT	Investor webinar and presentation	PRICE SENSITIVE	01/11/23	1.57MB	Share
VIT	Vitura Health completes acquisition of Doctors on Demand	PRICE SENSITIVE	26/10/23	247.54KB	Share
VIT	Vitura Health acquires Doctors on Demand	PRICE SENSITIVE	19/10/23	288.02KB	Share
VIT	Retraction of resolution	PRICE SENSITIVE	06/10/23	206.55KB	Share
VIT	Investor webinar and presentation	PRICE SENSITIVE	23/08/23	8.61MB	Share
VIT	Declaration of fully franked dividend	PRICE SENSITIVE	23/08/23	285.14KB	Share
VIT	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	23/08/23	60.32KB	Share
VIT	W.H.O. GDP certification and JV update	PRICE SENSITIVE	26/07/23	214.81KB	Share
VIT	Establishment of joint venture with Releaf Group	PRICE SENSITIVE	16/05/23	207.12KB	Share
VIT	Psychedelic joint venture with PharmAla Biotech	PRICE SENSITIVE	02/05/23	119.99KB	Share
VIT	Receipt of Shareholder Notice	PRICE SENSITIVE	12/04/23	95.16KB	Share
VIT	S&P DJI Announces March 2023 Quarterly Rebalance	PRICE SENSITIVE	03/03/23	128.97KB	Share
VIT	Half Yearly Report and Accounts	PRICE SENSITIVE	13/02/23	1.6MB	Share
VIT	Changes to clinical operations	PRICE SENSITIVE	16/01/23	243.82KB	Share
VIT	Sale of one millionth unit and record revenue in November	PRICE SENSITIVE	05/12/22	272.65KB	Share
VIT	Resolution of issues with major shareholder	PRICE SENSITIVE	28/11/22	242.26KB	Share
VIT	Response to ASX Price Query	PRICE SENSITIVE	15/11/22	356.04KB	Share
VIT	Investor presentation	PRICE SENSITIVE	25/10/22	2.63MB	Share
VIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	19/10/22	1.01MB	Share
VIT	Commissioning of new Melbourne Distribution Centre	PRICE SENSITIVE	12/10/22	268.27KB	Share
VIT	CanView 2.0 update	PRICE SENSITIVE	21/09/22	298.4KB	Share
VIT	Receipt of shareholder notice	PRICE SENSITIVE	20/09/22	256KB	Share
VIT	2022 financial results presentation deck	PRICE SENSITIVE	29/08/22	2.03MB	Share
VIT	Declaration of dividend and DRP	PRICE SENSITIVE	29/08/22	475.27KB	Share
VIT	Preliminary Final Report	PRICE SENSITIVE	29/08/22	1.9MB	Share
VIT	Investor presentation	PRICE SENSITIVE	25/07/22	10.01MB	Share
VIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	25/07/22	919.77KB	Share
VIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/22	653.35KB	Share
VIT	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/22	1.25MB	Share
VIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/01/22	1.33MB	Share
VIT	Response to ASX Price Query	PRICE SENSITIVE	05/01/22	272.49KB	Share
VIT	Completion of merger with CDA Health	PRICE SENSITIVE	16/12/21	124.94KB	Share
VIT	Chairman's Address to Shareholders	PRICE SENSITIVE	15/12/21	1.03MB	Share
VIT	Prospectus	PRICE SENSITIVE	19/11/21	1.69MB	Share
VIT	Changes to escrow arrangements	PRICE SENSITIVE	29/10/21	155.94KB	Share
VIT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/21	626.41KB	Share
VIT	Adaya sales update	PRICE SENSITIVE	15/10/21	165.78KB	Share
VIT	Response to ASX Price Query	PRICE SENSITIVE	20/09/21	145.69KB	Share
VIT	Merger with CDA Health Pty Ltd	PRICE SENSITIVE	14/09/21	1.9MB	Share
VIT	Preliminary Final Report	PRICE SENSITIVE	27/08/21	2.66MB	Share
VIT	Monthly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/21	622.23KB	Share
VIT	Adaya annual sales review and new product launch	PRICE SENSITIVE	12/07/21	165.94KB	Share
VIT	Launch of Saiph premium personal care range	PRICE SENSITIVE	25/06/21	238.33KB	Share
VIT	Bathing Shed progress update	PRICE SENSITIVE	03/06/21	243.86KB	Share
VIT	Adaya sales update	PRICE SENSITIVE	20/05/21	158.46KB	Share
VIT	ECS: Launches Innovative range of 30ml Terpene Blends	PRICE SENSITIVE	20/05/21	1.16MB	Share
VIT	Appendix 4C - quarterly	PRICE SENSITIVE	22/04/21	417.85KB	Share
VIT	Launch of FCTR CBD performance range	PRICE SENSITIVE	01/04/21	305.46KB	Share
VIT	Half Year Accounts	PRICE SENSITIVE	25/02/21	824.06KB	Share
VIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/21	607.96KB	Share
VIT	Launch of first personal care brand in Asia	PRICE SENSITIVE	16/12/20	153.78KB	Share
VIT	Chairman's Address to Shareholders	PRICE SENSITIVE	27/10/20	4.3MB	Share
VIT	Appendix 4C - quarterly	PRICE SENSITIVE	22/10/20	423.28KB	Share
VIT	Preliminary Final Report	PRICE SENSITIVE	28/08/20	1.27MB	Share
VIT	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	23/07/20	404.83KB	Share
VIT	Launch of Adaya Medicinal Cannabis oil range of products	PRICE SENSITIVE	01/07/20	185.12KB	Share
VIT	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	23/04/20	396.04KB	Share
VIT	Shareholder Update and Response to COVID-19	PRICE SENSITIVE	26/03/20	92.59KB	Share
VIT	Half Year Accounts	PRICE SENSITIVE	21/02/20	1.17MB	Share
VIT	Investment in Cannadoc Health	PRICE SENSITIVE	03/02/20	97.05KB	Share
VIT	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	24/01/20	401.22KB	Share
VIT	First shipment of Medicinal Cannabis products received	PRICE SENSITIVE	09/01/20	123.29KB	Share
VIT	Joint Venture with Co-Founders of Sukin Organic Skincare	PRICE SENSITIVE	23/12/19	93.09KB	Share
VIT	Distribution Agreement	PRICE SENSITIVE	15/11/19	91.53KB	Share
VIT	Suspension from Official Quotation (COB 6/12/2016)	PRICE SENSITIVE	06/12/16	79.3KB	Share
VIT	VIT shareholders approve scheme of arrangement	PRICE SENSITIVE	30/11/16	191.76KB	Share

VIT Flora JV acquires Heyday Medical Clinic
19/05/25	PRICE SENSITIVE	185.48KB	Share
VIT Q3 FY2025 business update
12/05/25	PRICE SENSITIVE	185.84KB	Share
VIT S&P DJI Announces March 2025 Quarterly Rebalance
07/03/25	PRICE SENSITIVE	174.42KB	Share
VIT Vitura completes acquisition of Canview platform
26/02/25	PRICE SENSITIVE	273.86KB	Share
VIT H1 FY2025 financial results
26/02/25	PRICE SENSITIVE	316.24KB	Share
VIT Appendix 4D
26/02/25	PRICE SENSITIVE	128.68KB	Share
VIT Vitura completes acquisition of Candor Medical
20/02/25	PRICE SENSITIVE	271.6KB	Share
VIT Vitura acquires Candor Medical
12/02/25	PRICE SENSITIVE	293.16KB	Share
VIT Vitura raises $5.1 million from Charlie Shahin AO
12/02/25	PRICE SENSITIVE	273.08KB	Share
VIT Trading Halt
11/02/25	PRICE SENSITIVE	283.83KB	Share
VIT Update regarding TGA proceedings
14/01/25	PRICE SENSITIVE	243.61KB	Share
VIT Vitura JV acquires assets of Releaf Group
19/11/24	PRICE SENSITIVE	282.92KB	Share
VIT Strategy Reset delivers positive Q1 results
28/10/24	PRICE SENSITIVE	251.14KB	Share
VIT Vitura settles dispute with Code4 Cannabis
17/10/24	PRICE SENSITIVE	247.51KB	Share
VIT Investor presentation
04/09/24	PRICE SENSITIVE	2.59MB	Share
VIT FY2024 Financial Results
29/08/24	PRICE SENSITIVE	292.73KB	Share
VIT ASX Appendix 4E - 30 June 2024
29/08/24	PRICE SENSITIVE	139.22KB	Share
VIT Geoff Cockerill appointed CEO of Vitura
27/08/24	PRICE SENSITIVE	278.76KB	Share
VIT VIT Strategy Reset Presentation
24/05/24	PRICE SENSITIVE	1.99MB	Share
VIT Vitura Strategy Reset
22/05/24	PRICE SENSITIVE	752.45KB	Share
VIT Update on Services Agreement with Code4 Cannabis
26/04/24	PRICE SENSITIVE	253.67KB	Share
VIT Services Agreement with Code4 Cannabis
23/04/24	PRICE SENSITIVE	255.28KB	Share
VIT Trading Halt
22/04/24	PRICE SENSITIVE	325.37KB	Share
VIT Pause in Trading
22/04/24	PRICE SENSITIVE	115.65KB	Share
VIT CEO transition
22/04/24	PRICE SENSITIVE	257.57KB	Share
VIT First supply of Psilocybin
18/03/24	PRICE SENSITIVE	270.26KB	Share
VIT Investor webinar and presentation
26/02/24	PRICE SENSITIVE	4.65MB	Share
VIT ASX Appendix 4D
26/02/24	PRICE SENSITIVE	57.21KB	Share
VIT Agreement executed with WholeLife Pharmacy Group
22/01/24	PRICE SENSITIVE	202.66KB	Share
VIT Vitura adds smoking cessation product vertical
09/01/24	PRICE SENSITIVE	212.62KB	Share
VIT Canview Services Agreement not to be extended
27/12/23	PRICE SENSITIVE	172.61KB	Share
VIT Sale of 2 millionth unit through CanView
11/12/23	PRICE SENSITIVE	211.47KB	Share
VIT Materials for 2023 Annual General Meeting
28/11/23	PRICE SENSITIVE	7.93MB	Share
VIT Cortexa update - product landed
08/11/23	PRICE SENSITIVE	213.29KB	Share
VIT Investor webinar and presentation
01/11/23	PRICE SENSITIVE	1.57MB	Share
VIT Vitura Health completes acquisition of Doctors on Demand
26/10/23	PRICE SENSITIVE	247.54KB	Share
VIT Vitura Health acquires Doctors on Demand
19/10/23	PRICE SENSITIVE	288.02KB	Share
VIT Retraction of resolution
06/10/23	PRICE SENSITIVE	206.55KB	Share
VIT Investor webinar and presentation
23/08/23	PRICE SENSITIVE	8.61MB	Share
VIT Declaration of fully franked dividend
23/08/23	PRICE SENSITIVE	285.14KB	Share
VIT Appendix 4E Preliminary Final Report
23/08/23	PRICE SENSITIVE	60.32KB	Share
VIT W.H.O. GDP certification and JV update
26/07/23	PRICE SENSITIVE	214.81KB	Share
VIT Establishment of joint venture with Releaf Group
16/05/23	PRICE SENSITIVE	207.12KB	Share
VIT Psychedelic joint venture with PharmAla Biotech
02/05/23	PRICE SENSITIVE	119.99KB	Share
VIT Receipt of Shareholder Notice
12/04/23	PRICE SENSITIVE	95.16KB	Share
VIT S&P DJI Announces March 2023 Quarterly Rebalance
03/03/23	PRICE SENSITIVE	128.97KB	Share
VIT Half Yearly Report and Accounts
13/02/23	PRICE SENSITIVE	1.6MB	Share
VIT Changes to clinical operations
16/01/23	PRICE SENSITIVE	243.82KB	Share
VIT Sale of one millionth unit and record revenue in November
05/12/22	PRICE SENSITIVE	272.65KB	Share
VIT Resolution of issues with major shareholder
28/11/22	PRICE SENSITIVE	242.26KB	Share
VIT Response to ASX Price Query
15/11/22	PRICE SENSITIVE	356.04KB	Share
VIT Investor presentation
25/10/22	PRICE SENSITIVE	2.63MB	Share
VIT Quarterly Activities/Appendix 4C Cash Flow Report
19/10/22	PRICE SENSITIVE	1.01MB	Share
VIT Commissioning of new Melbourne Distribution Centre
12/10/22	PRICE SENSITIVE	268.27KB	Share
VIT CanView 2.0 update
21/09/22	PRICE SENSITIVE	298.4KB	Share
VIT Receipt of shareholder notice
20/09/22	PRICE SENSITIVE	256KB	Share
VIT 2022 financial results presentation deck
29/08/22	PRICE SENSITIVE	2.03MB	Share
VIT Declaration of dividend and DRP
29/08/22	PRICE SENSITIVE	475.27KB	Share
VIT Preliminary Final Report
29/08/22	PRICE SENSITIVE	1.9MB	Share
VIT Investor presentation
25/07/22	PRICE SENSITIVE	10.01MB	Share
VIT Quarterly Activities/Appendix 4C Cash Flow Report
25/07/22	PRICE SENSITIVE	919.77KB	Share
VIT Quarterly Activities/Appendix 4C Cash Flow Report
28/04/22	PRICE SENSITIVE	653.35KB	Share
VIT Half Yearly Report and Accounts
25/02/22	PRICE SENSITIVE	1.25MB	Share
VIT Quarterly Activities/Appendix 4C Cash Flow Report
27/01/22	PRICE SENSITIVE	1.33MB	Share
VIT Response to ASX Price Query
05/01/22	PRICE SENSITIVE	272.49KB	Share
VIT Completion of merger with CDA Health
16/12/21	PRICE SENSITIVE	124.94KB	Share
VIT Chairman's Address to Shareholders
15/12/21	PRICE SENSITIVE	1.03MB	Share
VIT Prospectus
19/11/21	PRICE SENSITIVE	1.69MB	Share
VIT Changes to escrow arrangements
29/10/21	PRICE SENSITIVE	155.94KB	Share
VIT Quarterly Activities/Appendix 4C Cash Flow Report
28/10/21	PRICE SENSITIVE	626.41KB	Share
VIT Adaya sales update
15/10/21	PRICE SENSITIVE	165.78KB	Share
VIT Response to ASX Price Query
20/09/21	PRICE SENSITIVE	145.69KB	Share
VIT Merger with CDA Health Pty Ltd
14/09/21	PRICE SENSITIVE	1.9MB	Share
VIT Preliminary Final Report
27/08/21	PRICE SENSITIVE	2.66MB	Share
VIT Monthly Activities/Appendix 4C Cash Flow Report
29/07/21	PRICE SENSITIVE	622.23KB	Share
VIT Adaya annual sales review and new product launch
12/07/21	PRICE SENSITIVE	165.94KB	Share
VIT Launch of Saiph premium personal care range
25/06/21	PRICE SENSITIVE	238.33KB	Share
VIT Bathing Shed progress update
03/06/21	PRICE SENSITIVE	243.86KB	Share
VIT Adaya sales update
20/05/21	PRICE SENSITIVE	158.46KB	Share
VIT ECS: Launches Innovative range of 30ml Terpene Blends
20/05/21	PRICE SENSITIVE	1.16MB	Share
VIT Appendix 4C - quarterly
22/04/21	PRICE SENSITIVE	417.85KB	Share
VIT Launch of FCTR CBD performance range
01/04/21	PRICE SENSITIVE	305.46KB	Share
VIT Half Year Accounts
25/02/21	PRICE SENSITIVE	824.06KB	Share
VIT Appendix 4C - quarterly
27/01/21	PRICE SENSITIVE	607.96KB	Share
VIT Launch of first personal care brand in Asia
16/12/20	PRICE SENSITIVE	153.78KB	Share
VIT Chairman's Address to Shareholders
27/10/20	PRICE SENSITIVE	4.3MB	Share
VIT Appendix 4C - quarterly
22/10/20	PRICE SENSITIVE	423.28KB	Share
VIT Preliminary Final Report
28/08/20	PRICE SENSITIVE	1.27MB	Share
VIT Quarterly Activities Report and Appendix 4C
23/07/20	PRICE SENSITIVE	404.83KB	Share
VIT Launch of Adaya Medicinal Cannabis oil range of products
01/07/20	PRICE SENSITIVE	185.12KB	Share
VIT Quarterly Activities Report and Appendix 4C
23/04/20	PRICE SENSITIVE	396.04KB	Share
VIT Shareholder Update and Response to COVID-19
26/03/20	PRICE SENSITIVE	92.59KB	Share
VIT Half Year Accounts
21/02/20	PRICE SENSITIVE	1.17MB	Share
VIT Investment in Cannadoc Health
03/02/20	PRICE SENSITIVE	97.05KB	Share
VIT Quarterly Activities Report and Appendix 4C
24/01/20	PRICE SENSITIVE	401.22KB	Share
VIT First shipment of Medicinal Cannabis products received
09/01/20	PRICE SENSITIVE	123.29KB	Share
VIT Joint Venture with Co-Founders of Sukin Organic Skincare
23/12/19	PRICE SENSITIVE	93.09KB	Share
VIT Distribution Agreement
15/11/19	PRICE SENSITIVE	91.53KB	Share
VIT Suspension from Official Quotation (COB 6/12/2016)
06/12/16	PRICE SENSITIVE	79.3KB	Share
VIT VIT shareholders approve scheme of arrangement
30/11/16	PRICE SENSITIVE	191.76KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 7.2¢		Change 0.000(0.00%)		Mkt cap ! $47.68M

Open	High	Low	Value	Volume
7.2¢	7.2¢	7.1¢	$3.132K	44.00K

Buyers (Bids)

No.	Vol.	Price($)
3	44185	7.1¢

Sellers (Offers)

Price($)	Vol.	No.
7.2¢	68081	3

View Market Depth

No.	Vol.	Price($)
3	44185	0.071
2	23571	0.070
1	70000	0.069
2	108135	0.068
3	258958	0.066

Price($)	Vol.	No.
0.072	68081	3
0.073	20939	1
0.074	1709	1
0.075	41150	1
0.076	205000	1

Last trade - 14.34pm 11/08/2025 (20 minute delay)


Last 7.1¢		Change 0.000 ( 1.39 %)
Open	High	Low	Volume
7.1¢	7.2¢	7.1¢	5376
Last updated 14.57pm 11/08/2025 ?

VIT (ASX) Chart

VITURA HEALTH LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories